Controls serum phosphorus. ANDA 210464, held by Dr Reddys. Sevelamer Carbonate.
As of Nov 16, 2026, ANDA 210464 (Sevelamer Carbonate), held by Dr Reddys, was first approved by FDA on Oct 25, 2018, with 1 approved supplement and 0 published complete response letters.
Sevelamer carbonate for oral suspension is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 25, 2018 | Original application | Approved | None posted |
| Sevelamer Carbonate800MG/PACKET · for suspension;oral | Sevelamer Carbonate | Rx |
| Sevelamer Carbonate2.4GM/PACKET · for suspension;oral | Sevelamer Carbonate | Rx |
| May 25, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 25, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters